Phospholipid transfer protein deficiency decreases the content of S1P in HDL via the loss of its transfer capability

Lipids

Volumn 49, Issue 2, 2014, Pages 183-190

  Yu, Yang ^a   Guo, Shoudong ^a   Feng, Yumei ^b   Feng, Lei ^a   Cui, Yingjie ^a   Song, Guohua ^a   Luo, Tian ^a   Zhang, Ke ^c   Wang, Yiwei ^b   Jiang, Xian Cheng ^d   Qin, Shucun ^a  

^a TAISHAN MEDICAL UNIVERSITY   (China)

^b CHENGDE MEDICAL COLLEGE   (China)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

Apolipoprotein M; Erythrocyte; HDL; Phospholipid transfer protein; Sphingosine 1 phosphate

Indexed keywords

APOLIPOPROTEIN M; CARRIER PROTEIN; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; SPHINGOSINE 1 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL TRANSFER; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; ISCHEMIC HEART DISEASE; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; MOUSE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; PHOSPHOLIPID TRANSFER PROTEIN DEFICIENCY; PROTEIN DEFICIENCY; PROTEIN LOCALIZATION; WILD TYPE;

MUS;

ANIMALS; APOLIPOPROTEINS; BIOLOGICAL TRANSPORT; ERYTHROCYTES; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPID TRANSFER PROTEINS; SPHINGOSINE;

EID: 84895525573     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-013-3850-y     Document Type: Article

References (31)

1. Hajjar DP, Gotto AM Jr (2013) Biological relevance of inflammation and oxidative stress in the pathogenesis of arterial diseases. Am J Pathol 182:1474-1481
2. Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342-374
3. Takuwa Y, Okamoto Y, Yoshioka K et al (2012) Sphingosine-1-phosphate signaling in physiology and diseases. BioFactors 38:329-337
4. Fisher EA, Feig JE, Hewing B et al (2012) High-density lipoprotein function, dysfunction, and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 32:2813-2820
5. Yatomi Y, Ozaki Y, Ohmori T et al (2001) Sphingosine 1-phosphate: synthesis and release. Prostaglandins 64:107-122
6. Levkau B (2013) Cardiovascular Effects of Sphingosine-1-Phosphate (S1P). Handb Exp Pharmacol 216:147-170
7. Hanel P, Andreani P, Graler MH (2007) Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21:1202-1209
8. Pappu R, Schwab SR, Cornelissen I et al (2007) Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316:295-298
9. Christoffersen C, Obinata H, Kumaraswamy SB et al (2011) Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc Natl Acad Sci USA 108:9613-9618
10. Jiang XC, Bruce C, Mar J et al (1999) Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest 103:907-914
11. Schlitt A, Bickel C, Thumma P et al (2003) High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 23:1857-1862
12. Attia N, Nakbi A, Smaoui M et al (2007) Increased phospholipid transfer protein activity associated with the impaired cellular cholesterol efflux in type 2 diabetic subjects with coronary artery disease. Tohoku J Exp Med 213:129-137
13. Sattler KJ, Elbasan S, Keul P et al (2010) Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease. Basic Res Cardiol 105:821-832
14. Garcia-Pacios M, Collado MI, Busto JV et al (2009) Sphingosine-1- phosphate as an amphipathic metabolite: its properties in aqueous and membrane environments. Biophys J 97:1398-1407
15. Wang D, Han J, Yu Y et al (2011) Chitosan oligosaccharide decreases very-low-density lipoprotein triglyceride and increases high-density lipoprotein cholesterol in high-fat-diet-fed rats. Exp Biol Med (Maywood) 236:1064-1069
16. Schmidt H, Schmidt R, Geisslinger G (2006) LC-MS/MS-analysis of sphingosine-1-phosphate and related compounds in plasma samples. Prostaglandins Other Lipid Mediat 81:162-170
17. Zong C, Yu Y, Song G et al (2012) Chitosan oligosaccharides promote reverse cholesterol transport and expression of scavenger receptor BI and CYP7A1 in mice. Exp Biol Med (Maywood) 237:194-200
18. Post SM, de Crom R, van Haperen R et al (2003) Increased fecal bile acid excretion in transgenic mice with elevated expression of human phospholipid transfer protein. Arterioscler Thromb Vasc Biol 23:892-897
19. Argraves KM, Argraves WS (2007) HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects. J Lipid Res 48:2325-2333
20. Albers JJ, Vuletic S, Cheung MC (2012) Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. Biochim Biophys Acta 1821:345-357
21. Bode C, Sensken SC, Peest U et al (2010) Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J Cell Biochem 109:1232-1243
22. Faber K, Axler O, Dahlback B et al (2004) Characterization of apoM in normal and genetically modified mice. J Lipid Res 45:1272-1278
23. Sattler K, Levkau B (2009) Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Cardiovasc Res 82:201-211
24. Wilkerson BA, Grass GD, Wing SB et al (2012) Sphingosine 1-phosphate (S1P) carrier-dependent regulation of endothelial barrier: high density lipoprotein (HDL)-S1P prolongs endothelial barrier enhancement as compared with albumin-S1P via effects on levels, trafficking, and signaling of S1P1. J Biol Chem 287:44645-44653
25. Murata N, Sato K, Kon J et al (2000) Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352(Pt 3):809-815
26. Oram JF, Wolfbauer G, Tang C et al (2008) An amphipathic helical region of the N-terminal barrel of phospholipid transfer protein is critical for ABCA1-dependent cholesterol efflux. J Biol Chem 283:11541-11549
27. Parra ES, Panzoldo NB, Kaplan D et al (2012) The I405 V and Taq1B polymorphisms of the CETP gene differentially affect sub-clinical carotid atherosclerosis. Lipids Health Dis 11:130
28. Jiang XC, Qin S, Qiao C et al (2001) Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med 7:847-852
29. El-Shewy HM, Sohn M, Wilson P et al (2012) Low-density lipoprotein induced expression of connective tissue growth factor via transactivation of sphingosine 1-phosphate receptors in mesangial cells. Mol Endocrinol 26:833-845
30. Levkau B, Hermann S, Theilmeier G et al (2004) High-density lipoprotein stimulates myocardial perfusion in vivo. Circulation 110:3355-3359
31. Robins SJ, Lyass A, Brocia RW et al (2013) Plasma lipid transfer proteins and cardiovascular disease.The Framingham Heart Study. Atherosclerosis 228:230-236